0001209191-16-126311.txt : 20160607
0001209191-16-126311.hdr.sgml : 20160607
20160607172457
ACCESSION NUMBER: 0001209191-16-126311
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160603
FILED AS OF DATE: 20160607
DATE AS OF CHANGE: 20160607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ericson William W.
CENTRAL INDEX KEY: 0001503381
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 161702109
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD
STREET 2: BLDG 3 STE 290
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-03
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001503381
Ericson William W.
C/O MOHR DAVIDOW VENTURES
3000 SAND HILL ROAD, #3-290
MENLO PARK
CA
94025
1
0
1
0
Stock Option (Right to Buy)
17.03
2016-06-03
4
A
0
15000
0.00
A
2026-06-02
Common Stock
15000
15000
D
The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 3, 2016, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.
/s/William Dawson, as Attorney-in-Fact
2016-06-07